Stock Price Quote

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE628.30-4.6 (-0.73 %)
PREV CLOSE ( ) 632.90
OPEN PRICE ( ) 635.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 119160
TODAY'S LOW / HIGH ( )626.35 637.45
52 WK LOW / HIGH ( )356.75 646.8
NSE628.35-4.7 (-0.74 %)
PREV CLOSE( ) 633.05
OPEN PRICE ( ) 634.00
BID PRICE (QTY) 628.35 (1299)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5488725
TODAY'S LOW / HIGH( ) 626.05 637.65
52 WK LOW / HIGH ( )355.3 646.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000 / 022-24826951

Email cosecretary@cipla.com

Website www.cipla.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX

NEWS

21May Cipla, Tata Power and Natco Pharma to
Cipla has received final approval for its Abbreviated New Drug Applicati..
21May Cipla gets USFDA’s final approval for
Cipla has received final approval for its Abbreviated New Drug Applicati..
21May Cipla gains on getting USFDA’s final a
Cipla is currently trading at Rs. 624.20, up by 3.85 points or 0.62% fro..
18May Reliance Industries, Godrej Consumer P
General Atlantic is planning to invest Rs 6,598.38 crore in Jio Platform..
18May Cipla files ANDA for generic version o
Cipla has submitted an Abbreviated New Drug Application (ANDA) for Fluti..

Financials

in Millions
QTR Mar 20 ANNUAL 20
Net Profit6045.723181.7
Gross Profit 7085.5 29643.1
Operating Profit 8782.136001.4
Net Sales 31334.4126591.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Aarti Drugs (BSE)
peergroup  939.50 (6.77%)
M.Cap ( in Cr)2189.04
Valiant Organics (BSE)
peergroup  1329.00 (3.22%)
M.Cap ( in Cr)1614.63
Ajanta Pharma (BSE)
peergroup  1485.20 (2.72%)
M.Cap ( in Cr)12960.04
Procter&Gamble Healt (BSE)
peergroup  4079.65 (0.97%)
M.Cap ( in Cr)6771.97
Alembic Pharma (BSE)
peergroup  860.75 (3.03%)
M.Cap ( in Cr)16226.51

Shareholding Pattern

FI/BANKS/INSURANCE 5.54%
PROMOTERS 36.68%
NON-INSTITUTION 22.71%
MUTUAL FUNDS/UTI 16.93%
FII 0.01%
GOVERNMENT 0%

About Cipla Ltd.

Cipla Ltd. was incorporated in the year 1935. Its today's share price is 632.9. Its current market capitalisation stands at Rs 50656.01 Cr. In the latest quarter, company has reported Gross Sales of Rs. 239101.2 Cr and Total Income of Rs.168389.8 Cr. The company's management includes Naina Lal Kidwai, Punita Lal, Adil Zainulbhai, Peter Mugyenyi, Ashok Sinha, S Radhakrishnan, Umang Vohra, Samina Vaziralli, MK Hamied, Y K Hamied.

It is listed on the BSE with a BSE Code of 500087 , NSE with an NSE Symbol of CIPLA and ISIN of INE059A01026. It's Registered office is at Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower ParelMumbai-400013, Maharashtra. Their Registrars are ACC Ltd. It's auditors are RGN Price & Co, RS Bharucha & Co, V Sankar Aiyar & Co, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X